Literature DB >> 26085193

IGF-1 and Insulin Resistance Are Major Determinants of Common Carotid Artery Thickness in Morbidly Obese Young Patients.

Anca Sirbu1, Horia Nicolae2, Sorina Martin3, Carmen Barbu3, Catalin Copaescu4, Suzana Florea3, Cristina Panea2, Simona Fica5.   

Abstract

We assessed the relationship between insulin resistance, serum insulin-like growth factor 1 (IGF-1) levels, and common carotid intima-media thickness (CC-IMT) in morbidly obese young patients. A total of 249 patients (aged 37.9 ± 9.8 years, body mass index [BMI] 45.6 ± 8.3 kg/m(2)) were evaluated (metabolic tests, serum IGF-1 measurements, homeostasis model assessment-insulin resistance [HOMA-IR], and ultrasonographically assessed CC-IMT) in a research program for bariatric surgery candidates. After adjusting for age, gender, BMI, systolic blood pressure, uric acid, antihypertensive and lipid-lowering treatment, metabolic syndrome, and metabolic class, both HOMA-IR and IGF-1 z-score were significantly associated with CC-IMT. These results were confirmed in logistic regression analysis, in which age (β = 1.11, P = .001), gender (β = 3.19, P = .001), HOMA-IR (β = 1.221, P = .005), and IGF-1 z-score (β = 1.734, P = .009) were the only independent determinants of abnormal CC-IMT, presumably modulating the effect of the other risk factors included in the regression. Area under the receiver-operating characteristic curve for the model was 0.841 (confidence interval: 0.776-0.907; P < .001). In conclusion, in morbidly obese young adults, insulin resistance and IGF-1 z-score are significantly associated with CC-IMT, independent of other major cardiovascular risk factors.
© The Author(s) 2015.

Entities:  

Keywords:  IGF-1; IMT; atherosclerosis; insulin resistance; morbid obesity

Mesh:

Substances:

Year:  2015        PMID: 26085193     DOI: 10.1177/0003319715586499

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  7 in total

Review 1.  IGF-1 and cardiovascular disease.

Authors:  Yusuke Higashi; Sandeep Gautam; Patrick Delafontaine; Sergiy Sukhanov
Journal:  Growth Horm IGF Res       Date:  2019-01-31       Impact factor: 2.372

2.  Age-Related Effects of Bariatric Surgery on Early Atherosclerosis and Cardiovascular Risk Reduction.

Authors:  Frederik H W Jonker; Vera A A van Houten; Leontine H Wijngaarden; René A Klaassen; André A E A de Smet; André Niezen; Lodewijk J D M Schelfhout; Tobias A Bruning; Erwin van der Harst
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

Review 3.  PAPP-A and the IGF system in atherosclerosis: what's up, what's down?

Authors:  Lasse B Steffensen; Cheryl A Conover; Claus Oxvig
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-09-13       Impact factor: 4.733

4.  Declining Levels and Bioavailability of IGF-I in Cardiovascular Aging Associate With QT Prolongation-Results From the 1946 British Birth Cohort.

Authors:  Christos Charalambous; James C Moon; Jeff M P Holly; Nishi Chaturvedi; Alun D Hughes; Gabriella Captur
Journal:  Front Cardiovasc Med       Date:  2022-04-22

5.  Insulin-like growth factor-1 levels predict myocardial injury and infarction after elective percutaneous coronary intervention: an optical coherence tomography study.

Authors:  Onur Tasar; Gonenc Kocabay; Yavuz Karabag; Arzu Kalayci Karabay; Can Yucel Karabay; Sedat Kalkan; Cevat Kirma
Journal:  Postepy Kardiol Interwencyjnej       Date:  2020-06-23       Impact factor: 1.426

6.  Long-lived hypopituitary Ames dwarf mice are resistant to the detrimental effects of high-fat diet on metabolic function and energy expenditure.

Authors:  Cristal M Hill; Yimin Fang; Johanna G Miquet; Liou Y Sun; Michal M Masternak; Andrzej Bartke
Journal:  Aging Cell       Date:  2016-03-17       Impact factor: 9.304

7.  Association between the corrected QT interval, carotid artery intima-media thickness, and hepatic steatosis in obese children.

Authors:  Ghaniya Daar; Halil İbrahim Serin; Hüseyin Ede; Haşim Hüsrevşahi
Journal:  Anatol J Cardiol       Date:  2015-09-15       Impact factor: 1.596

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.